All Stories

  1. Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia

    Article • American Journal of Hematology, October 2018, Wiley

    Dr Jeffrey Lawrence Winters

  2. The use of cytapheresis in the treatment of infectious diseases

    Article • Journal of Clinical Apheresis, February 2018, Wiley

    Dr Jeffrey Lawrence Winters

  3. How shall we transfuse Hippolyta?

    Article • American Journal of Obstetrics and Gynecology, February 2018, Elsevier

    Dr Jeffrey Lawrence Winters

  4. Seeing is believing: A review of apheresis therapy in the treatment of ophthalmologic disease

    Article • Journal of Clinical Apheresis, November 2017, Wiley

    Dr Jeffrey Lawrence Winters

  5. Therapeutic plasma exchange causing (not curing) hemolysis

    Article • Journal of Clinical Apheresis, October 2017, Wiley

    Dr Jeffrey Lawrence Winters

  6. Paired comparison of therapeutic plasma exchange using the Fenwal Amicus versus TerumoBCTSpectra Optia

    Article • Journal of Clinical Apheresis, September 2017, Wiley

    Dr Jeffrey Lawrence Winters

  7. How I treat autoimmune hemolytic anemia

    Article • Blood, June 2017, American Society of Hematology

    Dr Jeffrey Lawrence Winters

  8. Iatrogenic thyrotoxicosis and the role of therapeutic plasma exchange

    Article • Journal of Clinical Apheresis, March 2017, Wiley

    Dr Jeffrey Lawrence Winters

  9. Therapeutic plasma exchange for perioperative management of patients with congenital factor XI deficiency

    Article • Journal of Clinical Apheresis, March 2017, Wiley

    Dr Jeffrey Lawrence Winters

  10. Apheresis illustrated: I can see it now

    Article • Journal of Clinical Apheresis, August 2016, Wiley

    Dr Jeffrey Lawrence Winters

  11. Red cell exchange for a case of babesiosis

    Article • Journal of Clinical Apheresis, August 2016, Wiley

    Dr Jeffrey Lawrence Winters

  12. What are the Newer Applications for Therapeutic Apheresis in Nephrology?

    Article • Seminars in Dialysis, July 2016, Wiley

    Dr Jeffrey Lawrence Winters

  13. Differences in Chronic Intragraft Inflammation Between Positive Crossmatch and ABO-Incompatible Kidney Transplantation

    Article • Transplantation, November 2014, Wolters Kluwer Health

    Dr Jeffrey Lawrence Winters

  14. Outcomes of plasma exchange in patients with transplant‐associated thrombotic microangiopathy based on time of presentation since transplant

    Article • Journal of Clinical Apheresis, September 2014, Wiley

    Dr Jeffrey Lawrence Winters

  15. National heart, lung, and blood institute state of the science symposium in therapeutic apheresis—Therapeutic apheresis in cardiovascular disease

    Article • Journal of Clinical Apheresis, September 2014, Wiley

    Dr Jeffrey Lawrence Winters

  16. Antibody-mediated rejection despite inhibition of terminal complement

    Article • Transplant International, August 2014, Frontiers

    Dr Jeffrey Lawrence Winters

  17. The entity of immunoglobulin A–related anaphylactic transfusion reactions is not evidence based

    Article • Transfusion, July 2014, Wiley

    Dr Jeffrey Lawrence Winters, SUMNER GERALD Sandler, Anne Eder

  18. Prospective Study on the Clinical Course and Outcomes in Transfusion-Related Acute Lung Injury*

    Article • Critical Care Medicine, July 2014, Wolters Kluwer Health

    Dr Jeffrey Lawrence Winters

  19. American society for apheresis guidelines on the use of apheresis in clinical practice: Practical, concise, evidence‐based recommendations for the apheresis practitioner

    Article • Journal of Clinical Apheresis, May 2014, Wiley

    Dr Jeffrey Lawrence Winters

  20. Immune Profiling to Predict Treatment Response from Extracorporeal Photopheresis in Graft-Versus-Host Disease

    Article • Biology of Blood and Marrow Transplantation, February 2014, Elsevier

    Dr Jeffrey Lawrence Winters

  21. Genetic and biochemical analyses in dyslipidemic patients undergoing LDL apheresis

    Article • Journal of Clinical Apheresis, January 2014, Wiley

    Dr Jeffrey Lawrence Winters

  22. Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis

    Article • Blood Research, January 2014, Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation

    Dr Jeffrey Lawrence Winters

  23. How we developed and use the American Society for Apheresis guidelines for therapeutic apheresis procedures

    Article • Transfusion, November 2013, Wiley

    Dr Jeffrey Lawrence Winters

  24. The mechanisms of action of plasma exchange

    Article • British Journal of Haematology, October 2013, Wiley

    Dr Jeffrey Lawrence Winters

  25. Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research

    Article • Journal of Clinical Apheresis, October 2013, Wiley

    Dr Jeffrey Lawrence Winters

  26. Cold agglutinins in patients undergoing cardiac surgery requiring cardiopulmonary bypass

    Article • Journal of Thoracic and Cardiovascular Surgery, September 2013, Elsevier

    Dr Jeffrey Lawrence Winters

  27. Discordant CD34+ cell results in peripheral blood and hematopoietic progenitor cell–apheresis product: implications for clinical decisions and impact on patient treatment

    Article • Transfusion, June 2013, Wiley

    Dr Jeffrey Lawrence Winters

  28. Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation

    Article • Eye, June 2013, Springer Science + Business Media

    Dr Jeffrey Lawrence Winters

  29. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

    Article • Journal of Clinical Apheresis, June 2013, Wiley

    Dr Jeffrey Lawrence Winters

  30. A multicenter evaluation of a new therapeutic plasma exchange procedure

    Article • Transfusion, April 2013, Wiley

    Dr Jeffrey Lawrence Winters

  31. Risk Factors and Outcomes in Transfusion-associated Circulatory Overload

    Article • The American Journal of Medicine, April 2013, Elsevier

    Dr Jeffrey Lawrence Winters

  32. Ticlopidine‐associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR)

    Article • British Journal of Haematology, March 2013, Wiley

    Dr Jeffrey Lawrence Winters, Professor and chair X. Long Zheng

  33. The fifth annual therapeutic apheresis academy: Continuity and changes

    Article • Journal of Clinical Apheresis, February 2013, Wiley

    Dr Jeffrey Lawrence Winters

  34. Randomized controlled trials in therapeutic apheresis

    Article • Journal of Clinical Apheresis, January 2013, Wiley

    Dr Jeffrey Lawrence Winters

  35. Lot‐to‐lot variability in HLA antibody screening using a multiplexed bead‐based assay

    Article • Transfusion, January 2013, Wiley

    Dr Jeffrey Lawrence Winters

  36. Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial

    Article • Trials, January 2013, Springer Science + Business Media

    Dr Jeffrey Lawrence Winters

  37. Cost-Effectiveness Analysis of a Risk-Adapted Algorithm of Plerixafor Use for Autologous Peripheral Blood Stem Cell Mobilization

    Article • Biology of Blood and Marrow Transplantation, January 2013, Elsevier

    Dr Jeffrey Lawrence Winters

  38. Five-Year Outcomes in Living Donor Kidney Transplants With a Positive Crossmatch

    Article • Arabian archaeology and epigraphy, January 2013, Elsevier

    Dr Jeffrey Lawrence Winters

  39. Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A 20-Year Review from the Southern Network on Adverse Reactions (SONAR)

    Article • Seminars in Thrombosis and Hemostasis, October 2012, Thieme Publishing Group

    Dr Jeffrey Lawrence Winters, Dr John Cursio, Professor and chair X. Long Zheng

  40. Drug-Associated Thrombotic Microangiopathies

    Article • Seminars in Thrombosis and Hemostasis, October 2012, Thieme Publishing Group

    Dr Jeffrey Lawrence Winters

  41. A FACTOR FOUND IN THE IGG FRACTION OF SERUM OF PATIENTS WITH PARANEOPLASTIC BILATERAL DIFFUSE UVEAL MELANOCYTIC PROLIFERATION CAUSES PROLIFERATION OF CULTURED HUMAN MELANOCYTES

    Article • Retina, October 2012, Wolters Kluwer Health

    Dr Jeffrey Lawrence Winters

  42. Milestones for Apheresis education

    Article • Journal of Clinical Apheresis, July 2012, Wiley

    Dr Jeffrey Lawrence Winters

  43. Plasma exchange as a therapeutic option in patients with neurologic symptoms due to antibodies to voltage‐gated potassium channels: A report of five cases and review of the literature

    Article • Journal of Clinical Apheresis, April 2012, Wiley

    Dr Jeffrey Lawrence Winters

  44. Fresh Red Blood Cell Transfusion and Short-Term Pulmonary, Immunologic, and Coagulation Status

    Article • American Review of Respiratory Disease, April 2012, American Thoracic Society

    Dr Jeffrey Lawrence Winters

  45. Transfusion-related acute lung injury: incidence and risk factors

    Article • Blood, February 2012, American Society of Hematology

    Dr Jeffrey Lawrence Winters

  46. Low‐Density Lipoprotein Apheresis: Principles and Indications

    Article • Seminars in Dialysis, January 2012, Wiley

    Dr Jeffrey Lawrence Winters

  47. Susac syndrome: clinical characteristics and treatment in 29 new cases

    Article • European Journal of Neurology, January 2012, Wiley

    Dr Jeffrey Lawrence Winters

  48. Apheresis in the treatment of idiopathic dilated cardiomyopathy

    Article • Journal of Clinical Apheresis, January 2012, Wiley

    Dr Jeffrey Lawrence Winters

  49. Evidence-based guideline update: Plasmapheresis in neurologic disorders

    Article • Neurology, October 2011, Wolters Kluwer Health

    Dr Jeffrey Lawrence Winters

  50. The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: A report of two cases

    Article • Journal of Clinical Apheresis, September 2011, Wiley

    Dr Jeffrey Lawrence Winters

  51. Early Reduction of Serum-Free Light Chains Associates with Renal Recovery in Myeloma Kidney

    Article • Journal of the American Society of Nephrology, June 2011, Wolters Kluwer Health

    Dr Jeffrey Lawrence Winters

  52. Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome

    Article • BMC Health Services Research, May 2011, Springer Science + Business Media

    Dr Jeffrey Lawrence Winters

  53. The Impact Of Red Blood Cell Storage Duration On Short-Term Pulmonary Function And Immunologic Status In Mechanically Ventilated Patients

    Article • May 2011, American Thoracic Society

    Dr Jeffrey Lawrence Winters

  54. A Cost Effective Analysis of a Risk-Adapted Algorithm for Plerixafor Use in Autologous Peripheral Blood Stem Cell Mobilization

    Article • Biology of Blood and Marrow Transplantation, February 2011, Elsevier

    Dr Jeffrey Lawrence Winters

  55. Lipid apheresis, indications, and principles

    Article • Journal of Clinical Apheresis, January 2011, Wiley

    Dr Jeffrey Lawrence Winters

  56. Manual color monitoring to optimize hematopoietic progenitor cell collection on the Fenwal Amicus

    Article • Journal of Clinical Apheresis, January 2011, Wiley

    Dr Jeffrey Lawrence Winters

  57. Comparison of hematopoietic progenitor cell collections using the COBE Spectra version 7 and Amicus version 3.1 for patients with al amyloidosis

    Article • Journal of Clinical Apheresis, January 2011, Wiley

    Dr Jeffrey Lawrence Winters

  58. Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis

    Article • Journal of Clinical Apheresis, January 2011, Wiley

    Dr Jeffrey Lawrence Winters

  59. Use of plasma exchange in patients with heparin‐induced thrombocytopenia: A report of two cases and a review of the literature

    Article • Journal of Clinical Apheresis, January 2011, Wiley

    Dr Jeffrey Lawrence Winters

  60. Evidence for the Role of B Cells and Immunoglobulins in the Pathogenesis of Multiple Sclerosis

    Article • Neurology Research International, January 2011, Hindawi Publishing Corporation

    Dr Jeffrey Lawrence Winters

  61. Hemapheresis

    Article • January 2011, Elsevier

    Dr Jeffrey Lawrence Winters

  62. Identification of anti-PP1Pk in a blood donor and her family: A case report following her pregnancy and review

    Article • Transfusion and Apheresis Science, December 2010, Elsevier

    Dr Jeffrey Lawrence Winters

  63. Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention

    Article • British Journal of Pharmacology, October 2010, Springer Science + Business Media

    Dr Jeffrey Lawrence Winters

  64. Polyethylene glycol antiglobulin tube versus gel microcolumn: influence on the incidence of delayed hemolytic transfusion reactions and delayed serologic transfusion reactions

    Article • Transfusion, July 2010, Wiley

    Dr Jeffrey Lawrence Winters

  65. Cancer‐associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic consideration

    Article • European Journal Of Haematology, June 2010, Wiley

    Dr Jeffrey Lawrence Winters

  66. Baseline Donor‐Specific Antibody Levels and Outcomes in Positive Crossmatch Kidney Transplantation

    Article • Arabian archaeology and epigraphy, March 2010, Elsevier

    Dr Jeffrey Lawrence Winters

  67. Use of various offset settings in the Fenwal Amicus during hematopoietic progenitor cell collection to increase lymphocyte yield and reduce cross‐cellular contamination

    Article • Journal of Clinical Apheresis, January 2010, Wiley

    Dr Jeffrey Lawrence Winters

  68. Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis

    Article • Journal of Clinical Apheresis, January 2010, Wiley

    Dr Jeffrey Lawrence Winters

  69. Thrombus formation during platelet donation

    Article • Transfusion, October 2009, Wiley

    Dr Jeffrey Lawrence Winters

  70. Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune‐mediated severe ADAMTS13‐deficiency: a report of four cases and a systematic review of the literature

    Article • European Journal Of Haematology, September 2009, Wiley

    Dr Jeffrey Lawrence Winters

  71. Transient neonatal acquired von Willebrand syndrome due to transplacental transfer of maternal monoclonal antibodies

    Article • Pediatric Blood & Cancer, August 2009, Wiley

    Dr Jeffrey Lawrence Winters

  72. Organ Procurement Organization Compliance with 21 CFR 1271: A Challenge for Allogeneic Pancreatic Islet Cell Transplantation Programs

    Article • Arabian archaeology and epigraphy, June 2009, Elsevier

    Dr Jeffrey Lawrence Winters

  73. Plasma exchange in pancreatitis due to hypertriglyceridemia

    Article • Transfusion, April 2009, Wiley

    Dr Jeffrey Lawrence Winters

  74. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh‐frozen plasma

    Article • Transfusion, March 2009, Wiley

    Dr Jeffrey Lawrence Winters

  75. Acquired von Willebrand syndrome: transplacental transfer of maternal monoclonal antibodies and description of peripartum management

    Article • Haemophilia, March 2009, Wiley

    Dr Jeffrey Lawrence Winters

  76. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989–2008)

    Article • Kidney International, February 2009, Elsevier

    Dr Jeffrey Lawrence Winters, Dr John Cursio, Professor and chair X. Long Zheng

  77. The accuracy of natriuretic peptides (brain natriuretic peptide and N‐terminal pro‐brain natriuretic) in the differentiation between transfusion‐related acute lung injury and transfusion‐related circulatory overload in the critically ill

    Article • Transfusion, December 2008, Wiley

    Dr Jeffrey Lawrence Winters

  78. Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma

    Article • British Journal of Pharmacology, November 2008, Springer Science + Business Media

    Dr Jeffrey Lawrence Winters

  79. THE ACCURACY OF NATRIURETIC PEPTIDES (BNP AND NT-PRO-BNP) IN THE DIFFERENTIATION BETWEEN TRANSFUSION-RELATED ACUTE LUNG INJURY (TRALI) AND TRANSFUSION-RELATED CIRCULATORY OVERLOAD (TACO) IN THE CRITICALLY ILL

    Article • CHEST Journal, October 2008, Elsevier

    Dr Jeffrey Lawrence Winters

  80. The effect of double‐ and triple‐apheresis platelet product donation on apheresis donor platelet and white blood cell counts

    Article • Transfusion, July 2008, Wiley

    Dr Jeffrey Lawrence Winters

  81. Early Lymphocyte Recovery Predicts Superior Survival after Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma: A Prospective Study

    Article • Biology of Blood and Marrow Transplantation, July 2008, Elsevier

    Dr Jeffrey Lawrence Winters

  82. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains

    Article • Kidney International, June 2008, Elsevier

    Dr Jeffrey Lawrence Winters

  83. Concentration changes to counteract the effects of bacteriological sampling on PLT yields

    Article • Journal of Clinical Apheresis, January 2008, Wiley

    Dr Jeffrey Lawrence Winters

  84. Transfusion-related Acute Lung Injury in the Critically Ill

    Article • American Review of Respiratory Disease, November 2007, American Thoracic Society

    Dr Jeffrey Lawrence Winters

  85. How we approach an apheresis request for a Category III, Category IV, or noncategorized indication

    Article • Transfusion, October 2007, Wiley

    Dr Jeffrey Lawrence Winters

  86. Reply

    Article • Transfusion, September 2007, Wiley

    Dr Jeffrey Lawrence Winters

  87. Treatment of chronic dilated cardiomyopathy with immunoadsorption using the staphylococcal A‐Agarose column: A comparison of immunoglobulin reduction using two different techniques

    Article • Journal of Clinical Apheresis, July 2007, Wiley

    Dr Jeffrey Lawrence Winters

  88. Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components*

    Article • Critical Care Medicine, July 2007, Wolters Kluwer Health

    Dr Jeffrey Lawrence Winters

  89. Fresh-Frozen Plasma and Platelet Transfusions Are Associated With Development of Acute Lung Injury in Critically Ill Medical Patients

    Article • CHEST Journal, May 2007, Elsevier

    Dr Jeffrey Lawrence Winters

  90. Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis

    Article • Journal of Clinical Apheresis, March 2007, Wiley

    Dr Jeffrey Lawrence Winters

  91. The new approach to assignment of ASFA categories—Introduction to the fourth special issue: Clinical applications of therapeutic apheresis

    Article • Journal of Clinical Apheresis, March 2007, Wiley

    Dr Jeffrey Lawrence Winters

  92. A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy

    Article • Journal of Clinical Apheresis, March 2007, Wiley

    Dr Jeffrey Lawrence Winters

  93. Category IV indications for therapeutic apheresis—ASFA fourth special issue

    Article • Journal of Clinical Apheresis, March 2007, Wiley

    Dr Jeffrey Lawrence Winters

  94. The addition of decision support into computerized physician order entry reduces red blood cell transfusion resource utilization in the intensive care unit

    Article • American Journal of Hematology, January 2007, Wiley

    Dr Jeffrey Lawrence Winters, Evans Fernández Pérez

  95. THE ADDITION OF DECISION SUPPORT INTO COMPUTERIZED PHYSICIAN ORDER ENTRY(CPOE) REDUCES RED BLOOD CELL TRANSFUSION RESOURCE UTILIZATION IN THE ICU.

    Article • Critical Care Medicine, December 2006, Wolters Kluwer Health

    Dr Jeffrey Lawrence Winters

  96. A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers

    Article • Transfusion, November 2006, Wiley

    Dr Jeffrey Lawrence Winters

  97. Histologic Findings One Year After Positive Crossmatch or ABO Blood Group Incompatible Living Donor Kidney Transplantation

    Article • Arabian archaeology and epigraphy, August 2006, Elsevier

    Dr Jeffrey Lawrence Winters

  98. Transfusion‐related acute lung injury and pulmonary edema in critically ill patients: a retrospective study

    Article • Transfusion, July 2006, Wiley

    Dr Jeffrey Lawrence Winters, Evans Fernández Pérez

  99. Evidence-based red cell transfusion in the critically ill: Quality improvement using computerized physician order entry*

    Article • Critical Care Medicine, July 2006, Wolters Kluwer Health

    Dr Jeffrey Lawrence Winters

  100. Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphoc...

    Article • British Journal of Pharmacology, March 2006, Springer Science + Business Media

    Dr Jeffrey Lawrence Winters

  101. A Comparison of Plasmapheresis Versus High-Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody

    Article • Arabian archaeology and epigraphy, February 2006, Elsevier

    Dr Jeffrey Lawrence Winters

  102. Complications of donor apheresis

    Article • Journal of Clinical Apheresis, January 2006, Wiley

    Dr Jeffrey Lawrence Winters

  103. A Comparison of Splenectomy versus Intensive Posttransplant Antidonor Blood Group Antibody Monitoring without Splenectomy in ABO-Incompatible Kidney Transplantation

    Article • Transplantation, December 2005, Wolters Kluwer Health

    Dr Jeffrey Lawrence Winters

  104. Clinical outcomes and mechanism of action for rheopheresis treatment of age-related macular degeneration (AMD)

    Article • Journal of Clinical Apheresis, January 2005, Wiley

    Dr Jeffrey Lawrence Winters

  105. Rheopheresis for macular degeneration: the data is not there yet to justify it

    Article • Journal of Clinical Apheresis, January 2005, Wiley

    Dr Jeffrey Lawrence Winters

  106. Paired comparison of Gambro Trima Accel versus Baxter Amicus single‐needle plateletpheresis

    Article • Transfusion, October 2004, Wiley

    Dr Jeffrey Lawrence Winters

  107. Transfusion of apheresis PLTs from IgA‐deficient donors with anti‐IgA is not associated with an increase in transfusion reactions

    Article • Transfusion, March 2004, Wiley

    Dr Jeffrey Lawrence Winters

  108. Hematopoietic progenitor cell large volume leukapheresis (LVL) on the Fenwal Amicus blood separator

    Article • Journal of Clinical Apheresis, January 2004, Wiley

    Dr Jeffrey Lawrence Winters

  109. Plasma exchange conditioning for ABO‐incompatible renal transplantation

    Article • Journal of Clinical Apheresis, January 2004, Wiley

    Dr Jeffrey Lawrence Winters

  110. New directions in plasma exchange

    Article • Current Opinion in Hematology, November 2003, Wolters Kluwer Health

    Dr Jeffrey Lawrence Winters

  111. Cold agglutinin disease

    Article • Transfusion, August 2003, Wiley

    Dr Jeffrey Lawrence Winters

  112. Multiple Blood Donations and Iron Deficiency in Patients With Restless Legs Syndrome

    Article • Mayo Clinic Proceedings, May 2003, Elsevier

    Dr Jeffrey Lawrence Winters

  113. Frozen preoperative autologous blood donation for heart transplantation at the Mayo Clinic from 1988 to 1999

    Article • Transfusion, April 2003, Wiley

    Dr Jeffrey Lawrence Winters

  114. RBC Tranfusion Threshold and Outcomes in the Medical Intensive Care Uni

    Article • CHEST Journal, January 2003, Elsevier

    Dr Jeffrey Lawrence Winters

  115. Comparative Performance of Herpes Simplex Virus Type 1-Specific Serologic Assays from MRL and Meridian Diagnostics

    Article • Journal of Clinical Microbiology, March 2002, ASM Journals

    Dr Jeffrey Lawrence Winters

  116. Absence of mutations in the HoxA10, HoxA11 and HoxD11 nucleotide coding sequences in thrombocytopenia with absent radius syndrome

    Article • British Journal of Haematology, February 2002, Wiley

    Dr Jeffrey Lawrence Winters

  117. RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota

    Article • Transfusion, November 2001, Wiley

    Dr Jeffrey Lawrence Winters

  118. Congenital glioblastoma multiforme: a report of three cases and a review of the literature

    Article • Journal of the Neurological Sciences, July 2001, Elsevier

    Dr Jeffrey Lawrence Winters

  119. TRANSFUSION 1999;39:1097‐1103.

    Article • Transfusion, July 2000, Wiley

    Dr Jeffrey Lawrence Winters

  120. Therapeutic apheresis in renal and metabolic diseases

    Article • Journal of Clinical Apheresis, January 2000, Wiley

    Dr Jeffrey Lawrence Winters

  121. Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions

    Article • Transfusion, October 1999, Wiley

    Dr Jeffrey Lawrence Winters

  122. Plasma exchange treatment for CNS inflammatory demyelinating disease

    Article • Cambridge University Press

    Dr Jeffrey Lawrence Winters